DEVELOPMENT OF DICLOFENAC SODIUM CONTROLLED-RELEASE SOLID DISPERSIONS BY SPRAY-DRYING USING OPTIMIZATION STRATEGY .1. POWDER FORMULATION

被引:16
作者
DANGPRASIRT, P [1 ]
RITTHIDEJ, GC [1 ]
机构
[1] CHULALONGKORN UNIV,FAC PHARMACEUT SCI,BANGKOK,THAILAND
关键词
D O I
10.3109/03639049509070872
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Diclofenac sodium (DS) controlled release solid dispersions were prepared by spray drying using ethylcellulose (EC), methacrylic acid copolymer (Eudragit), chitosan, hydroxypropyl methylcellulose (HPMC), and carbomer as single carriers and EC-chitosan as combined carriers. Among solid dispersions of 3:1 drug:single carrier, the system containing chitosan exhibited the slowest dissolution followed by the systems containing Eudragit, EC, HPMC, and carbomer, respectively. Combined carriers of EC-chitosan exhibited more dissolution retarding effect than single carrier of EC or chitosan. An Hadamard matrix H[8] was employed to estimate the main effects of four parameters: spray feeding volume and contents of absolute ethanol, EC, and chitosan. Optimization strategy using multiple linear regression and a feasibility computer program was utilized to obtain the optimum quantities of the four parameters that would result in a required DS controlled release solid dispersion. The validation of the optimum DS solid dispersion was confirmed by statistical analysis. The optimized 10:(2.5+0.02) DS:(EC+chitosan) controlled release solid dispersion exhibited a dissolution profile that was well fitted to Higuchi model.
引用
收藏
页码:2323 / 2337
页数:15
相关论文
共 15 条
[1]  
Abdou H. M., 1989, DISSOLUTION BIOAVAIL
[2]  
ALDERMAN D A, 1984, International Journal of Pharmaceutical Technology and Product Manufacture, V5, P1
[3]   PHARMACEUTICAL APPLICATIONS OF SOLID DISPERSION SYSTEMS [J].
CHIOU, WL ;
RIEGELMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1281-+
[4]  
Christian MA., 1990, ANAL PROFILES DRUG S, P123
[5]  
DUKKURI A, 1978, J PHARM SCI, V67, P354
[6]   SOLID DISPERSION CONTROLLED RELEASE - EFFECT OF PARTICLE-SIZE, COMPRESSION FORCE AND TEMPERATURE [J].
FASSIHI, AR ;
PARKER, MS ;
POURKAVOOS, N .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1985, 11 (2-3) :523-535
[7]   COPRECIPITATES OF TRIFLUOPERAZINE EMBONATE AND POLYMERS - DURATION OF ACTION BY INTRAMUSCULAR ROUTE [J].
FLORENCE, AT ;
HAQ, ME ;
LOVELESS, AH .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (07) :601-602
[8]  
FORD JL, 1986, PHARM ACTA HELV, V61, P69
[9]  
KALVELGEN K, 1990, EXPLORING OPERATIONS
[10]  
Montgomery D.C., 1984, DESIGN ANAL EXPT